ReAlta Life Sciences
About
No comments yet. Be the first to share your take.
What does ReAlta Life Sciences do?
ReAlta Life Sciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for inflammatory and hypoxic diseases. Their lead candidate, Pegtarazimod, is being investigated for Hypoxic Ischemic Encephalopathy (HIE). The company leverages its proprietary platform to discover and develop treatments for a range of serious medical conditions.
How much funding has ReAlta Life Sciences raised?
ReAlta Life Sciences has raised a total of $55M in funding. The most recent round on record is Funding Round.
Where is ReAlta Life Sciences headquartered?
ReAlta Life Sciences is headquartered in Norfolk, Virginia, USA.
When was ReAlta Life Sciences founded?
ReAlta Life Sciences was founded in 2016.
What industry does ReAlta Life Sciences operate in?
ReAlta Life Sciences operates in Biotechnology, Pharmaceuticals, Healthcare, Biotech, Drug Discovery, Clinical Trials.
What is ReAlta Life Sciences's revenue?
StartupHub estimates ReAlta Life Sciences's annual revenue at $8.2M (range $2.5M to $22.4M, 34% confidence), based on comparable companies in the sector.
What is ReAlta Life Sciences's valuation?
StartupHub estimates ReAlta Life Sciences's effective valuation at $224.4M (range $137.5M to $330.0M, 23% confidence), based on comparable companies in the sector.